Abstract:Cell-intrinsic reporters such as luciferase (LUC) and red fluorescent protein (RFP) have been commonly utilized in preclinical studies to image tumor growth and to monitor therapeutic responses. While extrinsic reporters that emit near infrared I (NIR-I: 650-950 nm) or near-infrared II (NIR-II: 1000 -1700 nm) optical signals have enabled minimization of tissue autofluorescence and light scattering, it has remained unclear as to whether their use has afforded more accurate tumor imaging in small animals. Here, we developed a novel optical imaging construct comprised of rare earth lanthanide nanoparticles coated with biodegradable diblock copolymers and doped with organic fluorophores, generating NIR-I and NIR-II emissive bands upon optical excitation. Simultaneous injection of multiple spectrally-unique nanoparticles into mice bearing tumor implants established via intraperitoneal dissemination of LUC+/ RFP+ OVCAR-8 ovarian cancer cells enabled direct comparisons of imaging with extrinsic vs. intrinsic reporters, NIR-II vs. NIR-I signals, as well as targeted vs. untargeted exogenous contrast agents in the same animal and over time. We discovered that in vivo optical imaging at NIR-II wavelengths facilitates more accurate detection of smaller and earlier tumor deposits, offering enhanced sensitivity, improved spatial contrast, and increased depths of tissue penetration as compared to imaging with visible or NIR-I fluorescent agents. Our work further highlights the hitherto underappreciated enhancements in tumor accumulation that may be achieved with intraperitoneal as opposed to intravenous administration of nanoparticles. Lastly, we found discrepancies in the fidelity of tumor uptake that could be obtained by utilizing small molecules for in vivo as opposed to in vitro targeting of nanoparticles to disseminated tumors. (C) 2017 Elsevier Ltd. All rights reserved.

Tracking of Intestinal Probiotics In Vivo by NIR-IIb Fluorescence Imaging

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Metabolic Labeling of Peptidoglycan with NIR‐II Dye Enables in Vivo Imaging of Gut Microbiota

In Vivo Dynamic Monitoring of Bacterial Infection by NIR-II Fluorescence Imaging.

DNA-mediated Au@Ag@silica nanopopcorn fluorescent probe for in vivo near-infrared imaging of probiotic Lactobacillus Plantarum

Long-term monitoring of intravital biological processes using fluorescent protein-assisted NIR-II imaging

In Vivo High-resolution Ratiometric Fluorescence Imaging of Inflammation Using NIR-II Nanoprobes with 1550 Nm Emission

Real-Time in Vivo Detection and Monitoring of Bacterial Infection Based on NIR-II Imaging

High Spatial and Temporal Resolution NIR-IIb Gastrointestinal Imaging in Mice

Developing A Bright Nir-Ii Fluorophore With Fast Renal Excretion And Its Application In Molecular Imaging Of Immune Checkpoint Pd-L1

Lighting up intestinal inflammation in situ with a pH-insensitive NIR fluorescent probe

Fluorescence Lifetime Imaging of Upper Gastrointestinal Ph in Vivo with a Lanthanide Based Near-Infrared Τ Probe

Quaternary Ammonium Salt Based NIR‐II Probes for In Vivo Imaging

Near-infrared II fluorescent carbon dots for differential imaging of drug-resistant bacteria and dynamic monitoring of immune system defense against bacterial infection in vivo

An Antigen-Strengthened Dye-Modified Fully-Human-nanobody-based Immunoprobe for Second Near Infrared Bioimaging of Metastatic Tumors

time imaging of upper gastrointestinal pH in vivo with a lanthanide based near-infrared s probe †

In vivo NIR-II fluorescence imaging for biology and medicine

An intestinal-targeting near-infrared probe for imaging nitroreductase in inflammatory bowel disease

NIR-II Fluorescence Imaging for In Vivo Quantitative Analysis

Near-infrared fluorescent probes for non-invasive, real-time, and dual-color in vivo NIR-II imaging

Molecular Engineering of Activatable NIR-II Hemicyanine Reporters for Early Diagnosis and Prognostic Assessment of Inflammatory Bowel Disease